(NASDAQ: SPRB) Spruce Biosciences's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 14.13%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 19.95%.
Spruce Biosciences's earnings in 2025 is -$39,427,000.On average, 3 Wall Street analysts forecast SPRB's earnings for 2025 to be -$35,107,209, with the lowest SPRB earnings forecast at -$42,128,651, and the highest SPRB earnings forecast at -$25,194,585. On average, 1 Wall Street analyst forecast SPRB's earnings for 2026 to be -$61,127,847, with the lowest SPRB earnings forecast at -$61,127,847, and the highest SPRB earnings forecast at -$61,127,847.
In 2027, SPRB is forecast to generate -$69,801,392 in earnings, with the lowest earnings forecast at -$69,801,392 and the highest earnings forecast at -$69,801,392.